These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2606292)

  • 1. Measuring quality of life in clinical drug trials.
    Michalko KJ
    Dimens Health Serv; 1989 Nov; 66(8):16-8, 20. PubMed ID: 2606292
    [No Abstract]   [Full Text] [Related]  

  • 2. Taking quality of life into account in health economic analyses.
    Weeks J
    J Natl Cancer Inst Monogr; 1996; (20):23-7. PubMed ID: 8750463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Containing pharmacy costs: back to basics.
    Giaquinta D
    Manag Care Interface; 1999 Oct; 12(10):56-7. PubMed ID: 10623008
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring quality of life in clinical trials: a taxonomy and review.
    Guyatt GH; Veldhuyzen Van Zanten SJ; Feeny DH; Patrick DL
    CMAJ; 1989 Jun; 140(12):1441-8. PubMed ID: 2655856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group.
    Osoba D; Dancey J; Zee B; Myles J; Pater J
    J Natl Cancer Inst Monogr; 1996; (20):107-11. PubMed ID: 8750480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.
    Brundage M; Osoba D; Bezjak A; Tu D; Palmer M; Pater J;
    J Clin Oncol; 2007 Nov; 25(32):5078-81. PubMed ID: 17991924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inclusion of health-related quality of life studies alongside clinical trials: basis and practical recommendations. Utilization of a check-list for their correct desing and evaluation].
    Soto Alvarez J
    An Med Interna; 2003 Dec; 20(12):633-44. PubMed ID: 14697086
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating patient-based outcome measures for use in clinical trials.
    Fitzpatrick R; Davey C; Buxton MJ; Jones DR
    Health Technol Assess; 1998; 2(14):i-iv, 1-74. PubMed ID: 9812244
    [No Abstract]   [Full Text] [Related]  

  • 10. Felicitometry: measuring the 'quality' in quality of life.
    Kowalski C; Pennell S; Vinokur A
    Bioethics; 2008 Jul; 22(6):307-13. PubMed ID: 18522590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pharmaceuticals reduce cost of illness.
    Hansen RW
    CPJ; 1986 Jun; 119(6):318-20, 323-5. PubMed ID: 10311615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of health-related quality-of-life measures for pediatric patients: application in the assessment of pharmacotherapeutic and pharmacoeconomic outcomes.
    Marra CA; Levine M; McKerrow R; Carleton BC
    Pharmacotherapy; 1996; 16(5):879-88. PubMed ID: 8888083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA; Kirsch JM; Bala MV; Chambers MG; Harpole LH
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in head and neck cancer patients.
    Borghgraef K; Delaere P; Van den Bogaert W; Feenstra L
    Acta Otorhinolaryngol Belg; 1997; 51(2):69-72. PubMed ID: 9241370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling health-related quality of life: the bridge between psychometric and utility-based measures.
    Erickson P
    J Natl Cancer Inst Monogr; 1996; (20):17-22. PubMed ID: 8750462
    [No Abstract]   [Full Text] [Related]  

  • 16. [The quality of life of diabetic patients--literature review].
    Suwalska A; Górna K; Lojko D; Rybakowski J
    Przegl Lek; 2004; 61(9):940-1. PubMed ID: 15803903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cooperative group report on quality-of-life research: lessons learned.
    McCabe MS
    J Natl Cancer Inst Monogr; 1996; (20):63-5. PubMed ID: 8750468
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug therapy: safety, effectiveness, and economics.
    Brandys J
    Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis assessment tools in clinical trials.
    Feldman SR; Krueger GG
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii65-8; discussion ii69-73. PubMed ID: 15708941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design.
    Sullivan MD; Anderson RT; Aron D; Atkinson HH; Bastien A; Chen GJ; Feeney P; Gafni A; Hwang W; Katz LA; Narayan KM; Nwachuku C; O'Connor PJ; Zhang P;
    Am J Cardiol; 2007 Jun; 99(12A):90i-102i. PubMed ID: 17599429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.